Latest Cancer News

U.S. Food and Drug Administration Approves EmplicitiĀ® Plus Pomalidomide to Treat Certain Patients with Relapsed or Refractory Multiple Myeloma (11-12-2018)
The U.S. Food and Drug Administration (FDA) has approved Empliciti (elotuzumab) injection for intravenous use in combination with pomalidomide and dexamethasone (EPd) for the treatment of adult patients... Continue Reading

Lorbrena Approved for second- or third-line treatment of ALK-positive metastatic NSCLC (11-8-2018)
The US Food and Drug Administration granted accelerated approval to Lorbrena (lorlatinib) for the treatment of patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer... Continue Reading

FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC (11-5-2018)
On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small... Continue Reading

More Cancer News

Locations

Montana Cancer Center
500 West Broadway
Missoula, Montana 59807